CORD-19:8ba20a12c92103d82364b8abca49cfcd91d91c13 / 0-90 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/8ba20a12c92103d82364b8abca49cfcd91d91c13","sourcedb":"CORD-19","sourceid":"8ba20a12c92103d82364b8abca49cfcd91d91c13","text":"N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients NIH ","tracks":[{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1","span":{"begin":61,"end":76},"obj":"Disease"},{"id":"T84499","span":{"begin":61,"end":76},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"id":"A62994","pred":"mondo_id","subj":"T84499","obj":"http://purl.obolibrary.org/obo/MONDO_0008315"},{"subj":"T1","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T84499","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T1","span":{"begin":61,"end":76},"obj":"Phenotype"},{"id":"T2","span":{"begin":70,"end":76},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0012125"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"subj":"T1","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T2","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-PD-MONDO","color":"#9cec93","default":true},{"id":"CORD-19-PD-HP","color":"#ec93b7"}]}]}}